tiprankstipranks
Harvard Bioscience (HBIO)
NASDAQ:HBIO
Holding HBIO?
Track your performance easily

Harvard Bioscience (HBIO) Ownership - Who Owns Harvard Bioscience?

184 Followers

Harvard Bioscience (HBIO) Ownership Overview

10.81%19.76%37.47%9.58%22.38%
10.81% Insiders
37.47% Other Institutional Investors
9.58% ETFs
22.38% Public Companies and
Individual Investors
The ownership structure of Harvard Bioscience (HBIO) stock is a mix of institutional, retail, and individual investors. Approximately 66.81% of the company’s stock is owned by Institutional Investors, 10.81% is owned by Insiders, and 22.38% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 14, 2024
James W. Green
Ceo,director
xxxxxxxxxxxxx
$29100
Jun 07, 2024
James W. Green
Ceo,director
xxxxxxxxxxxxx
$61400

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$3904400
Sep 30, 2024
xxxxxxxxxxxxx
$7303350

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,111,091Insider7.13%6,719,957
2,715,000Institution6.22%5,864,400
2,060,695Institution4.72%4,451,101
1,841,679Institution4.22%3,978,027
1,483,539Institution3.40%3,204,444
1,451,450Institution3.33%3,135,132
1,200,000Institution2.75%2,592,000
1,035,689Institution2.37%2,237,088
932,577Institution2.14%2,014,366
556,208Insider1.28%1,201,409

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,841,679Institution4.22%3,978,027
1,200,000Institution2.75%2,592,000
1,035,689Institution2.37%2,237,088
932,577Institution2.14%2,014,366
440,934Institution1.01%952,417
384,569Institution0.88%830,669
344,113Institution0.79%743,284
282,422Institution0.65%610,032
252,032Institution0.58%544,389
239,942Institution0.55%518,275

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,261,693Institution2.89%2,964,979
1,003,682Institution2.30%2,167,953
579,986Institution1.33%1,362,967
262,513Institution0.60%567,028
257,164Institution0.59%555,474
185,645Institution0.43%436,266
126,680Institution0.29%273,629
104,348Institution0.24%225,392
92,800Institution0.21%200,448
78,555Institution0.18%169,679

FAQ

Who Owns Harvard Bioscience (HBIO)?
According to the latest TipRanks data, approximately 37.47% of the company's stock is held by institutional investors, 10.81% is held by insiders, and 22.38% is held by retail investors.
    What percentage of Harvard Bioscience (HBIO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 37.47% of Harvard Bioscience (HBIO) stock is held by institutional investors.
      What percentage of Harvard Bioscience (HBIO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 22.38% of Harvard Bioscience (HBIO) stock is held by retail investors.
        Who owns the most shares of Harvard Bioscience (HBIO)?
        James W. Green owns the most shares of Harvard Bioscience (HBIO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis